Evidence map›Paper›PMID 42386722›Full record

ArticleNature communications2026

A deep learning framework for efficient pathology image analysis.

Peter Neidlinger, Tim Lenz, Sebastian Foersch, Chiara M L Loeffler, Jan Clusmann, Marco Gustav, Lawrence A Shaktah, Rupert Langer, Bastian Dislich, Lisa A Boardman and 17 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Peter NeidlingerElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0009-0006-9416-1498
Tim LenzElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Sebastian FoerschInstitute of Pathology, University Medical Center Mainz, Mainz, Germany.ORCID 0000-0002-4740-6900
Chiara M L LoefflerElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Jan ClusmannElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
Marco GustavElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0009-0009-3598-5720
Lawrence A ShaktahElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.ORCID 0009-0003-0923-9712
Rupert LangerInstitute of Pathology and Molecular Pathology, Kepler University Hospital, Johannes Kepler University Linz, Linz, Austria.
Bastian DislichInstitute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
Lisa A BoardmanDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-1330-2054
Amy J FrenchDivision of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Ellen L GoodeDepartment of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-9094-8326
Andrea GsurCenter for Cancer Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-9795-1528
Stefanie BrezinaCenter for Cancer Research, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5238-6900
Marc J GunterNutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Robert SteinfelderDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0003-4204-8013
Hans-Michael BehrensDepartment of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany.
Christoph RöckenDepartment of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0002-6989-8002
Tabitha HarrisonDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0002-4173-7530
Ulrike PetersDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.ORCID 0000-0001-5666-9318
Amanda I PhippsDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Giuseppe CuriglianoDivision of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-1781-2518
Nicola FuscoDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.ORCID 0000-0002-9101-9131
Antonio MarraDivision of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-7310-7824
Michael HoffmeisterDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-8307-3197
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-6129-1572
Jakob Nikolas KatherElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany. jakob-nikolas.kather@alumni.dkfz.de.ORCID 0000-0002-3730-5348

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Lila J. Rutten · 1985 to 2026
$151.3M
WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER: TASK AREA B - LONG LIFE STUDY VISIT 2 LIMITED HOME VISIT75N92021D00001 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L. · 2021 to 2025
$52.0M
Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8M
Translational Research Program in Cancer Differences across PopulationsP50CA285275 · NCI · FRED HUTCHINSON CANCER CENTER · PI ULRIKE PETERS · 2024 to 2026
$9.9M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A275N92021D00002 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI WACTAWSKI-WENDE, JEAN · 2021 to 2025
$6.9M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00004 · NHLBI · STANFORD UNIVERSITY · PI STEFANICK, MARCIA · 2021 to 2025
$6.5M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00003 · NHLBI · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA · 2021 to 2025
$5.0M
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCSR01CA065435 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI WILSON, JESSE FRANK · 1994 to 2009
$5.0M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00005 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI VITOLINS, MARA · 2021 to 2025
$4.2M
Translational Research Program in Colorectal Cancer DisparitiesP20CA252733 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LI, CHRISTOPHER I · 2020 to 2022
$3.4M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
Breast Cancer Research Foundation (BCRF) (BELLADONNA, BCRF-25-225)Cancer Research UK C8221/A29017Cancer Research UK GRANT 14136Deutsche Forschungsgemeinschaft (German Research Foundation) EXC 2050/2 - Project ID 390696704, (TRR 412/1, 535081457; SFB 1709/1 2025, 533056198)Deutsche Krebshilfe (German Cancer Aid) (DECADE, 70115166)Deutscher Akademischer Austauschdienst (German Academic Exchange Service) (SECAI, 57616814)DH | National Institute for Health Research (NIHR) (Leeds Biomedical Research Centre, NIHR203331)Medical Research Council Grant 1000143Medical Research Council Grant MR/M012190/1NCI NIH HHS HHSN261201000032CNCI NIH HHS HHSN268201700006INCI NIH HHS P20 CA252733NCI NIH HHS P30 CA015083NCI NIH HHS P30 CA015704NCI NIH HHS P50 CA285275NCI NIH HHS R01 CA065435NCI NIH HHS R01 CA107333NCI NIH HHS R01 CA488857NCI NIH HHS U01 CA137088NHLBI NIH HHS 75N92021D00001NHLBI NIH HHS 75N92021D00002NIH HHS S10 OD028685WHI NIH HHS 75N92021D00003WHI NIH HHS 75N92021D00004WHI NIH HHS 75N92021D00005
6 · The paper itself

Abstract

Artificial intelligence has transformed digital pathology by enabling biomarker prediction from high-resolution whole-slide images. However, current methods are computationally inefficient, processing thousands of redundant tiles per slide and requiring complex aggregation models. We introduce EAGLE (Efficient Approach for Guided Local Examination), a deep learning framework that emulates pathologists by selectively analyzing informative regions. EAGLE combines task-agnostic tile selection with detailed feature extraction and is benchmarked against leading slide- and tile-level foundation models across 43 tasks from nine cancer types spanning morphology, biomarker prediction, treatment response and prognosis. EAGLE outperforms patch aggregation methods by up to 23% and achieves the highest overall classification performance. It processes one slide in 2.27 s, reducing computational time by more than 99% compared with existing models. This efficiency supports rapid and auditable workflows by enabling review of the exact tiles used for each prediction and reducing dependence on high-performance computing. By reliably identifying informative regions and minimizing artifacts, EAGLE provides robust and auditable outputs, supported by systematic negative controls and attention concentration analyses. Its unified embedding enables rapid slide search, integration into multi-omics pipelines and emerging clinical foundation models.

Indexed as

Deep LearningImage Processing, Computer-AssistedNeoplasmsHumans

Identifiers

PMID42386722
PMCPMC13324285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.